share_log

UroGen Pharma Ltd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.6%),Point72 Capital Advisors, Inc.(3.6%), etc.

乌龙制药 | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(3.6%),Point72 Capital Advisors, Inc.(3.6%)等

美股SEC公告 ·  2024/11/15 08:52
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息